These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7260651)

  • 1. Differential functional ontogeny of dopamine presynaptic receptor regulation.
    Shalaby IA; Dendel PS; Spear LP
    Brain Res; 1981 Jun; 227(3):434-9. PubMed ID: 7260651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM; Spear LP
    Psychopharmacology (Berl); 1985; 85(3):271-6. PubMed ID: 3923514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC; Moore KE; Demarest KT
    J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-tolerance of dopamine metabolism to baclofen, gamma-butyrolactone and HA-966 in the striatum and olfactory tubercle of the rat.
    Broxterman HJ; Noach EL; van Valkenburg CF; Wijling A
    Life Sci; 1981 Mar; 28(9):973-81. PubMed ID: 7219068
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic prenatal haloperidol exposure: lack of effect on presynaptic dopamine autoreceptors.
    Scalzo FM; Newport GD; Gough BJ; Ali SF; Holson RR
    Neurotoxicology; 1989; 10(3):485-90. PubMed ID: 2516618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function.
    Kelly PH; Moore KE
    Nature; 1976 Oct; 263(5579):695-6. PubMed ID: 980114
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.
    Meller E; Helmer-Matyjek E; Bohmaker K; Adler CH; Friedhoff AJ; Goldstein M
    Eur J Pharmacol; 1986 Apr; 123(2):311-4. PubMed ID: 3709668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.
    Gudelsky GA; Moore EK
    J Neural Transm; 1976; 38(2):95-105. PubMed ID: 1271052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D; Hjorth S; Carlsson A
    Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain dopamine autoreceptors in aging rats.
    Carfagna N; Trunzo F; Moretti A
    Exp Gerontol; 1986; 21(3):169-75. PubMed ID: 3803468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.
    Marek KL; Roth RH
    Eur J Pharmacol; 1980 Mar; 62(2-3):137-46. PubMed ID: 6769681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certain dopamine agonists increase dopamine synthesis in the striatum of rat brain.
    Westerink BH; Feenstra MG; Wirix E; Horn AS
    Eur J Pharmacol; 1984 Jun; 101(3-4):235-41. PubMed ID: 6432559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.
    German DC; McMillen BA; Sanghera MK; Saffer SI; Shore PA
    Brain Res Bull; 1981 Feb; 6(2):131-4. PubMed ID: 6110470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors.
    Meller E; Bohmaker K; Goldstein M; Basham DA
    Eur J Pharmacol; 1993 Nov; 249(1):R5-6. PubMed ID: 7904244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions.
    Costa E; Cheney DL; Racagni G; Zsilla G
    Life Sci; 1975 Jul; 17(1):1-8. PubMed ID: 167253
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced apomorphine sensitivity of dopamine metabolism in rat striatum after repeated administration of methamphetamine.
    Kashihara K; Sato M; Fukuda K; Fujiwara Y; Otsuki S
    Neurosci Res; 1986 May; 3(4):351-5. PubMed ID: 3725224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.